Hepatitis C virus gets personal

Shawn P. Iadonato and Michael G. Katze
Additional contact information
Shawn P. Iadonato: Shawn P. Iadonato is at Kineta, Inc., 307 Westlake Avenue North, Seattle, Washington 98109, USA. siadonato@kinetabio.com
Michael G. Katze: University of Washington, Seattle, Washington 98195-8070, USA. honey@u.washington.edu

Nature, 2009, vol. 461, issue 7262, 357-358

Abstract: Many people infected with the hepatitis C virus are not cured despite gruelling therapy. A human genetic variant that predicts successful treatment has been identified. So is personalized therapy now a possibility?

Date: 2009
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/461357a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:461:y:2009:i:7262:d:10.1038_461357a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/461357a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().